IMMUNOLOGICAL HETEROGENEITY OF CEA
IMMUNOLOGICAL HETEROGENEITY OF CEA
批准号:
3175274
负责人:
F. JAMES PRIMUS
金额:
$19.05万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 1988-01-31
关键词:
adenocarcinoma affinity chromatography antibody formation antigen antibody reaction antiserum carcinoembryonal antigen colitis cross immunity electrophoresis human subject immunochemistry immunoprecipitation ion exchange chromatography metastasis molecular sieving monoclonal antibody neoplasm /cancer immunodiagnosis neoplasm /cancer immunology radioimmunoassay radiotracer tumor antigens
中文摘要
总的目标是确定抗原谱和免疫化学
英文摘要
The general objective is to define the antigenic profile and immunochemical
characteristics of carcinoembryonic antigen (CEA) of the human digestive
system and to study the interrelationships of CEA, nonspecific
cross-reacting antigen (NCA), and two CEA-related meconium antigens. Using
antibodies isolated from conventional antisera against unique and common
specificities on CEA, the immunochemical nature of CEA appearing in plasma
and tissue from normal individuals and patients with malignant and
nonmalignant gastrointestinal disease will be characterized according to
size and lectin binding properties. The physicochemical, immunochemical,
and tissue specificity properties of the CEA-like meconium antigens will be
determined and compared to those of CEA and NCA. The interrelationships in
the expression of CEA and CEA-like antigens will be studied in plasma and
tissue specimens. Murine monoclonal antibodies will be developed against
CEA obtained from colonic and gastric cancer as well as against the
CEA-like antigens to define further the antigenic specification of CEA and
related antigens. A clearer definition of the immunochemical profile of
CEA and related antigens would allow a more complete understanding of their
interrelationships and provide opportunities to evaluate them with regard
to tissue specificity, response to therapy, patient survival, and cancer
cell evolution. (2)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FUSION PROTEINS AGAINST CARCINOEMBRYONIC ANTIGEN
-
批准号:6093684
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2000
-
负责人:F. JAMES PRIMUS
-
依托单位:
FUSION PROTEINS AGAINST CARCINOEMBRYONIC ANTIGEN
-
批准号:6514480
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2000
-
负责人:F. JAMES PRIMUS
-
依托单位:
FUSION PROTEINS AGAINST CARCINOEMBRYONIC ANTIGEN
-
批准号:6377832
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2000
-
负责人:F. JAMES PRIMUS
-
依托单位:
FUSION PROTEINS AGAINST CARCINOEMBRYONIC ANTIGEN
-
批准号:6633699
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2000
-
负责人:F. JAMES PRIMUS
-
依托单位:
TRANSGENIC MODEL FOR CARCINOEMBRYONIC ANTIGEN VACCINES
-
批准号:2683646
-
项目类别:
-
资助金额:$27.1万
-
财政年份:1996
-
负责人:F. JAMES PRIMUS
-
依托单位:
TRANSGENIC MODEL FOR CARCINOEMBRYONIC ANTIGEN VACCINES
-
批准号:2390921
-
项目类别:
-
资助金额:$26.19万
-
财政年份:1996
-
负责人:F. JAMES PRIMUS
-
依托单位:
TRANSGENIC MODEL FOR CARCINOEMBRYONIC ANTIGEN VACCINES
-
批准号:2114231
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1996
-
负责人:F. JAMES PRIMUS
-
依托单位:
TRANSGENIC MODEL FOR CARCINOEMBRYONIC ANTIGEN VACCINES
-
批准号:2114232
-
项目类别:
-
资助金额:$4.13万
-
财政年份:1996
-
负责人:F. JAMES PRIMUS
-
依托单位:
TUMOR CELL TARGETED IMMUNOGLOBULIN GENE THERAPY
-
批准号:2560976
-
项目类别:
-
资助金额:$14.08万
-
财政年份:1994
-
负责人:F. JAMES PRIMUS
-
依托单位:
TUMOR CELL TARGETED IMMUNOGLOBULIN GENE THERAPY
-
批准号:2099040
-
项目类别:
-
资助金额:$23.5万
-
财政年份:1994
-
负责人:F. JAMES PRIMUS
-
依托单位:
TUMOR CELL TARGETED IMMUNOGLOBULIN GENE THERAPY
-
批准号:2099042
-
项目类别:
-
资助金额:$11.78万
-
财政年份:1994
-
负责人:F. JAMES PRIMUS
-
依托单位:
TUMOR CELL TARGETED IMMUNOGLOBULIN GENE THERAPY
-
批准号:2099041
-
项目类别:
-
资助金额:$20.27万
-
财政年份:1994
-
负责人:F. JAMES PRIMUS
-
依托单位:
TUMOR CELL-TARGETED IMMUNOGLOBULIN GENE THERAPY
-
批准号:3509636
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1993
-
负责人:F. JAMES PRIMUS
-
依托单位:
EXPERIMENTAL IMMUNOTHERAPY OF CANCER
-
批准号:3175014
-
项目类别:
-
资助金额:$22.97万
-
财政年份:1984
-
负责人:F. JAMES PRIMUS
-
依托单位:
EXPERIMENTAL IMMUNOTHERAPY OF CANCER
-
批准号:3175013
-
项目类别:
-
资助金额:$22.86万
-
财政年份:1984
-
负责人:F. JAMES PRIMUS
-
依托单位:
海外基金